Cargando…

Linear growth and endocrine function in children with ataxia telangiectasia

INTRODUCTION: Ataxia telangiectasia (AT) is a rare, genetic, primary immune deficiency disease characterized by immunodeficiency and neurological manifestations, with an increased tendency to infection, malignancy, and autoimmune diseases. Both growth delay and endocrine abnormalities are occasional...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ehlayel, Mohammad, Soliman, Ashraf, De Sanctis, Vincenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266876/ https://www.ncbi.nlm.nih.gov/pubmed/25538885 http://dx.doi.org/10.4103/2230-8210.145079

Ejemplares similares

Growth in ataxia telangiectasia
por: Natale, Valerie A. I., et al.
Publicado: (2021)

Correction to: Growth in ataxia telangiectasia
por: Natale, Valerie A. I., et al.
Publicado: (2021)

Dysarthria in children and adults with ataxia telangiectasia
por: Veenhuis, Stefanie J G, et al.
Publicado: (2021)

Altered Cerebrospinal Fluid (CSF) in Children with Ataxia Telangiectasia
por: Woelke, S., et al.
Publicado: (2020)

The Role of Respiratory Viruses in Children with Ataxia-Telangiectasia
por: Méndez-Echevarría, Ana, et al.
Publicado: (2021)

Myoclonus in Ataxia–Telangiectasia
por: Termsarasab, Pichet, et al.
Publicado: (2015)

Imaging in children with ataxia-telangiectasia—The radiologist’s approach
por: Jończyk-Potoczna, Katarzyna, et al.
Publicado: (2022)

Ataxia-telangiectasia: future prospects
por: Chaudhary, Mohammed Wajid, et al.
Publicado: (2014)

Ataxia telangiectasia: Family management
por: Seshachalam, Arun, et al.
Publicado: (2010)

Ataxia telangiectasia: a review
por: Rothblum-Oviatt, Cynthia, et al.
Publicado: (2016)

Ataxia-Telangiectasia Mutated Is Involved in Autolysosome Formation
por: Hwang, Mihwa, et al.
Publicado: (2023)

Prevalence of thyroid dysfunctions in infants and children with Down Syndrome (DS) and the effect of thyroxine treatment on linear growth and weight gain in treated subjects versus DS subjects with normal thyroid function: a controlled study
por: AlAaraj, Nada, et al.
Publicado: (2019)

Bladder Wall Telangiectasia in a Patient with Ataxia-Telangiectasia and How to Manage?
por: Aygün, Fatma Deniz, et al.
Publicado: (2015)

Experimental Antioxidant Therapy in Ataxia Telangiectasia
por: Reliene, Ramune, et al.
Publicado: (2008)

Treatment of Granulomas in Patients With Ataxia Telangiectasia
por: Woelke, Sandra, et al.
Publicado: (2018)

Ataxia Telangiectasia Presenting as Cervical Dystonia
por: LNU, Priyal, et al.
Publicado: (2022)

Classic ataxia-telangiectasia: the phenotype of long-term survivors
por: van Os, Nienke J. H., et al.
Publicado: (2019)

Positive effect of erythrocyte-delivered dexamethasone in ataxia-telangiectasia
por: Leuzzi, Vincenzo, et al.
Publicado: (2015)

Nicotinamide Riboside Improves Ataxia Scores and Immunoglobulin Levels in Ataxia Telangiectasia
por: Veenhuis, Stefanie J.G., et al.
Publicado: (2021)

Ataxia-telangiectasia: immunologic profile and clinical outcome
por: De Lima Honório Dumas, Clarissa, et al.
Publicado: (2015)

Free-Living Motor Activity Monitoring in Ataxia-Telangiectasia
por: Khan, Nergis C., et al.
Publicado: (2021)

Linear growth and prevalence of the different components of the metabolic syndrome (MetS) in young obese nondiabetic children (below 5 years) in comparison to older obese children (6-12 years)
por: Hamed, Noor, et al.
Publicado: (2022)

Newborn Screening for SCID Identifies Patients with Ataxia Telangiectasia
por: Mallott, Jacob, et al.
Publicado: (2012)

MEK inhibitors block growth of lung tumours with mutations in ataxia–telangiectasia mutated
por: Smida, Michal, et al.
Publicado: (2016)

Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma
por: Pastorino, Lorenza, et al.
Publicado: (2022)

The impact of iron overload in patients with acute leukemia and myelodysplastic syndrome on hepatic and endocrine functions
por: Yassin, Mohamed A, et al.
Publicado: (2018)

Disorders of Upper Limb Movements in Ataxia-Telangiectasia
por: Shaikh, Aasef G., et al.
Publicado: (2013)

Ataxia Telangiectasia in Siblings: Oral Motor and Swallowing Characterization
por: Rondon-Melo, Silmara, et al.
Publicado: (2017)

A new ataxia-telangiectasia mutation in an 11-year-old female
por: Mortaz, Esmaeil, et al.
Publicado: (2017)

Clinical and Biochemical Data of Adult Thalassemia Major patients (TM) with Multiple Endocrine Complications (MEC) versus TM Patients with Normal Endocrine Functions: A long-term Retrospective Study (40 years) in a Tertiary Care Center in Italy
por: De Sanctis, Vincenzo, et al.
Publicado: (2016)

JIA-like in a boy with Ataxia-telangiectasia
por: Furtado, Filipa, et al.
Publicado: (2014)

Nonalcoholic Steatohepatitis in a Patient with Ataxia-Telangiectasia
por: Caballero, Trinidad, et al.
Publicado: (2014)

Retroperitoneal extramedullary hematopoietic pseudotumor in ataxia–telangiectasia
por: Judge, Sean James, et al.
Publicado: (2018)

Progressive Liver Disease in Patients With Ataxia Telangiectasia
por: Donath, Helena, et al.
Publicado: (2019)

Metabolic Stress and Mitochondrial Dysfunction in Ataxia-Telangiectasia
por: Subramanian, Goutham Narayanan, et al.
Publicado: (2022)

Multidisciplinary Management of Ataxia Telangiectasia: Current Perspectives
por: McGrath-Morrow, Sharon A, et al.
Publicado: (2021)

Genetic Risk Variants for Class Switching Recombination Defects in Ataxia-Telangiectasia Patients
por: Amirifar, Parisa, et al.
Publicado: (2021)

Ten new ATM alterations in Polish patients with ataxia-telangiectasia
por: Podralska, Marta Joanna, et al.
Publicado: (2014)

An anaplerotic approach to correct the mitochondrial dysfunction in ataxia-telangiectasia (A-T)
por: Yeo, A.J., et al.
Publicado: (2021)

Neurofilament Light Chain Is a Biomarker of Neurodegeneration in Ataxia Telangiectasia
por: Donath, H., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a1sj2cf95nlbct0ubvaq548m0m